Documents
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma
Hemminki Kari, Liu Xiangdong, Försti Asta, Ji Jianguang, Sundquist Jan, Sundquist, Sundquist Kristina
Documents
In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival
Thulien, Belch, Reiman Tony, Pilarski
Documents
Bendamustine in patients with relapsed or refractory multiple myeloma
Bruns I, Bölke E, Zohren F, Czibere A, Safaian, Neumann F, Haas R, Kobbe G, Fenk, Fenk R, Michaelm
Documents
The value of plasma cell immunophenotypic analysis estimating response to treatment and risk of multiple myeloma ; Plazminių ląstelių imunofenotipinės analizės reikšmė vertinant mielominės ligos riziką ir atsaką į gydymą
User1
Documents
Determination of intrarenal resistance index (RI) in patients with multiple myeloma
Schiemann U, Kaiser Hc, Götzberger M, Schmidmaier R, Bantle F, Straka, Straka C
Documents
Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-XLexpression
Badr Gamal, Mohany Mohamed, Abu-Tarboush, Abu-Tarboush Faisal
Documents
Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
Kafasi Nikolitsa, Bartzis Vassiliki, Dimou Maria, Mirbahai Ladan, Kyrtsonis Marie-Christine, Koulieris Efstathios, Panayiotidis Panayiotis, Harding, Maltezas Dimitris, Tzenou Tatiana, Georgiou George, Bradwell
Documents
Savoirs
Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
Kafasi Nikolitsa, Bartzis Vassiliki, Dimou Maria, Mirbahai Ladan, Kyrtsonis Marie-Christine, Koulieris Efstathios, Panayiotidis Panayiotis, Harding, Maltezas Dimitris, Tzenou Tatiana, Georgiou George, Bradwell
7 pages
English
Documents
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
Chim Chor, Lie, Lau Ching, Yip Sze, Sim Joycelyn, Wan Thomas, Ma Edmond, Liang Raymond, Tse Eric, Kwong Yok-Lam, Liu, Chan, For
Documents
Savoirs
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
Chim Chor, Lie, Lau Ching, Yip Sze, Sim Joycelyn, Wan Thomas, Ma Edmond, Liang Raymond, Tse Eric, Kwong Yok-Lam, Liu, Chan, For
7 pages
English
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
{{productCategoryLabel}}
{{productTitle}}
{{productAuthors}}
{{productCategoryLabel}}
{{productThemeLabel}}
{{productTitle}}
{{productAuthors}}
{{productPages}}
{{productLanguageIsoCode}}